Christopher Viehbacher

BIIB

Christopher Viehbacher serves as director at Biogen Inc. (BIIB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.50M

Total Sells

3 trades

$3.27M

Net Position

Net Seller

$1.77M

Companies Traded

BRVE, BIIB

Active Period

Feb 2025 – Aug 2026

4 total trades

Most Recent

Buy BRVE

Aug 7, 2026 · $1.50M

Christopher Viehbacher's Insider Trading at Biogen Inc. (BIIB)

Buys

0 · $0.00

Sells

3 · $3.27M

Total Shares Bought

Total Shares Sold

17,585

BIIB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 6, 2026	Sell	10,980	$201.18	$2.21M
Dec 3, 2025	Sell	3,404	$177.78	$605.2K
Feb 10, 2025	Sell	3,201	$141.35	$452.5K

Christopher Viehbacher's Insider Trading at BRVE (BRVE)

Buys

1 · $1.50M

Sells

0 · $0.00

Total Shares Bought

83,333

Total Shares Sold

BRVE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 7, 2026	Buy	83,333	$18.00	$1.50M	609,519

Related Insiders

Erez Chimovits

director, 10 percent owner:

BRVEBuy · Aug 11, 2026

AH Bio Fund IV, L.P.

10 percent owner

BRVEBuy · Aug 11, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

BRVEBuy · Aug 11, 2026

Travis Murdoch

director, officer: CEO and President

BRVEBuy · Aug 7, 2026

Michele A. Anderson

officer: Chief Development Officer

BRVEBuy · Aug 7, 2026

David I Malek

director

BRVEBuy · Aug 7, 2026

Forbion Growth Opportunities Fund III Cooperatief U.A.

10 percent owner

BRVEBuy · Aug 7, 2026

David Charles Lubner

director

BRVEBuy · Aug 7, 2026

Explore More Insider Trading Data

BIIB Insider Trading Activity

View all insider trades at Biogen Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity